The sub-study of the phase III trial of the NVX-CoV2373 COVID-19 vaccine (Novavax), published in Lancet Respiratory Medicine, is among the first to examine the safety, immunogenicity, and efficacy of co-administration of a COVID-19 vaccine and seasonal flu shot.